Healthcare provider profile · identity verified

Mandeep Kaur Singh, MD

Family Practice · ARCADIA, CA · NPI 1386176352

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	382	144
Amlodipine Besylate	Amlodipine Besylate	255	85
Lisinopril	Lisinopril	167	59
Levothyroxine Sodium	Levothyroxine Sodium	159	55
Metformin Hcl	Metformin Hcl	100	38
Losartan Potassium	Losartan Potassium	96	35
Hydrochlorothiazide	Hydrochlorothiazide	87	30
Omeprazole	Omeprazole	83	31
Rosuvastatin Calcium	Rosuvastatin Calcium	82	29
Gabapentin	Gabapentin	75	32
Carvedilol	Carvedilol	68	19
Metoprolol Succinate	Metoprolol Succinate	54	18
Albuterol Sulfate Hfa	Albuterol Sulfate	53	32
Alendronate Sodium	Alendronate Sodium	52	18
Simvastatin	Simvastatin	50	19
Zolpidem Tartrate	Zolpidem Tartrate	50	11
Escitalopram Oxalate	Escitalopram Oxalate	48	17
Fluticasone Propionate	Fluticasone Propionate	48	17
Pantoprazole Sodium	Pantoprazole Sodium	46	15
Furosemide	Furosemide	44	22
Glipizide	Glipizide	44	12
Duloxetine Hcl	Duloxetine Hcl	43	16
Pravastatin Sodium	Pravastatin Sodium	41	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	18
Tramadol Hcl	Tramadol Hcl	40	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	15
Montelukast Sodium	Montelukast Sodium	39	16
Famotidine	Famotidine	37	17
Sildenafil Citrate	Sildenafil Citrate	37	suppressed
Eliquis	Apixaban	36	13
Lovastatin	Lovastatin	35	12
Tamsulosin Hcl	Tamsulosin Hcl	34	13
Chlorthalidone	Chlorthalidone	33	14
Lorazepam	Lorazepam	33	suppressed
Benazepril Hcl	Benazepril Hcl	31	14
Irbesartan	Irbesartan	31	13
Ozempic	Semaglutide	31	suppressed
Valsartan	Valsartan	31	12
Alprazolam	Alprazolam	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	23
Trazodone Hcl	Trazodone Hcl	27	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	13
Azithromycin	Azithromycin	25	23
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	13
Diclofenac Sodium	Diclofenac Sodium	23	18
Prednisone	Prednisone	23	22
Allopurinol	Allopurinol	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Temazepam	Temazepam	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Atenolol	Atenolol	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Ibuprofen	Ibuprofen	20	12
Metformin Hcl Er	Metformin Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	18
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Baclofen	Baclofen	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Potassium Chloride	Potassium Chloride	16	suppressed
Methylprednisolone	Methylprednisolone	15	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Finasteride	Finasteride	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Naproxen	Naproxen	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Sertraline Hcl	Sertraline Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error